BIORETEC OY - Asset Resilience Ratio
BIORETEC OY (0TN) has an Asset Resilience Ratio of 26.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how BIORETEC OY's Asset Resilience Ratio has changed over time. See 0TN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down BIORETEC OY's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 0TN stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €3.04 Million | 26.06% |
| Total Liquid Assets | €3.04 Million | 26.06% |
Asset Resilience Insights
- Very High Liquidity: BIORETEC OY maintains exceptional liquid asset reserves at 26.06% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BIORETEC OY Industry Peers by Asset Resilience Ratio
Compare BIORETEC OY's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
APT Medical Inc
SHG:688617 |
Medical Devices | 8.63% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
Annual Asset Resilience Ratio for BIORETEC OY (2021–2025)
The table below shows the annual Asset Resilience Ratio data for BIORETEC OY.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 26.06% | €3.04 Million ≈ $3.56 Million |
€11.68 Million ≈ $13.65 Million |
+4.68pp |
| 2024-12-31 | 21.37% | €2.45 Million ≈ $2.87 Million |
€11.47 Million ≈ $13.42 Million |
-7.96pp |
| 2023-12-31 | 29.33% | €3.13 Million ≈ $3.65 Million |
€10.66 Million ≈ $12.46 Million |
+0.22pp |
| 2022-12-31 | 29.11% | €1.02 Million ≈ $1.19 Million |
€3.49 Million ≈ $4.08 Million |
-46.15pp |
| 2021-12-31 | 75.27% | €6.46 Million ≈ $7.55 Million |
€8.58 Million ≈ $10.03 Million |
-- |
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more